DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Generic Name: oxandrolone

Summary for Generic Name: oxandrolone

Tradenames:2
Patents:4
Applicants:5
NDAs:6
Drug Master File Entries: see list9
Suppliers: see list1
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details

Clinical Trials for: oxandrolone

Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia
Status: Completed Condition: Fanconi Anemia

Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer
Status: Completed Condition: Unspecified Adult Solid Tumor, Protocol Specific; Weight Changes

Bioavailability Study of Oxandrolone Tablets Under Fasting Conditions
Status: Completed Condition: To Determine the Bioequivalence Under Fasting Conditions

Pilot Study of the Safety and Efficacy of Oxandrolone in the Prevention and Treatment of Malnutrition in Infants
Status: Completed Condition: Malnutrition

Pilot Study of Goal-Directed Iron Supplementation +/- Oxandrolone for Functional Iron Deficiency of Critical Illness
Status: Not yet recruiting Condition: Functional Iron Deficiency; Trauma; Anemia

Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's Syndrome
Status: Completed Condition: Turner's Syndrome

Oxandrolone to Heal Pressure Ulcers
Status: Terminated Condition: Pressure Ulcer

Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)
Status: Completed Condition: Muscular Dystrophies

The Use of Anabolic Steroids to Improve Function After Spinal Cord Injury
Status: Completed Condition: Spinal Cord Injury

Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation
Status: Recruiting Condition: Burns

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Crealta Pharms Llc
OXANDRIN
oxandrolone
TABLET;ORAL013718Approved Prior to Jan 1, 1982RXNo5,872,147<disabled>TO PROMOTE WEIGHT GAIN AFTER WEIGHT LOSS IN CERTAIN TYPES OF PATIENTS
Crealta Pharms Llc
OXANDRIN
oxandrolone
TABLET;ORAL013718Approved Prior to Jan 1, 1982RXNo6,090,799<disabled>TO PROMOTE WEIGHT GAIN AFTER WEIGHT LOSS IN CERTAIN TYPES OF PATIENTS
Crealta Pharms Llc
OXANDRIN
oxandrolone
TABLET;ORAL013718Approved Prior to Jan 1, 1982RXNo6,576,659<disabled>TO PROMOTE WEIGHT GAIN AFTER WEIGHT LOSS IN CERTAIN TYPES OF PATIENTS
Crealta Pharms Llc
OXANDRIN
oxandrolone
TABLET;ORAL013718Approved Prior to Jan 1, 1982RXNo6,828,313<disabled>TO PROMOTE WEIGHT GAIN AFTER WEIGHT LOSS IN CERTAIN TYPES OF PATIENTS
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc